Sorafenib Eugia

Medicinal product

(Invented) name

Sorafenib Eugia

Active substance (s)

Sorafenibas

Strength

200 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01EX02, sorafenib

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2026-09-11

Date of renewal

Documents

3590_Sorafenib_Eugia_PL.docx

3590_Sorafenib_Eugia_PZ.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Sorafenibas	200 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
122277	108390	1108390	lizdinė plokštelė	N112		Receptinis	LT/L/26/3590/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2026-09-11	Registruotas